TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Risk of pressure injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: faecal bifidobacterial relative abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance of HEARTBiT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome of personality disorder treatment after 8 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement with EFIC for personal enrollment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Agreement with general use of EFIC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Odor-intensity ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orthonasal and retronasal test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in sore throat symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in hoarseness symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in vocal cord leukoplakia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily micturitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary ITT endpoint achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of cabotegravir + rilpivirine LA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for LA injections over daily oral tablets
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time spent in the clinic for injections
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total intolerance rate
Endpoint domain: Adverse events/effects
Primary endpoint: Preoperative counseling time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: STOP-Bang score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Fecal bifidobacteria abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Community Integration Scale psychological score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rosenberg Self-Esteem Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Donation behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to intervene against suicide
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Median 24-h intragastric pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: pH4 HTRs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Risk of primary outcome events
Endpoint domain: Mortality/survival
Primary endpoint: Completion of the 90-day interview
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Emotion Regulation Checklist score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: onset time of sensory and motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: recovery time of sensory and motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: degree of nerve block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change in PCS score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Glycemic indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hypertensive events
Endpoint domain: Adverse events/effects
Primary endpoint: Tachycardia events
Endpoint domain: Adverse events/effects
Primary endpoint: ESSDAI score reduction of at least 3 points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in infection
Endpoint domain: Adverse events/effects
Primary endpoint: Neonatal Infant Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal toxicity (CrCl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: wire-bending scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Error in the time production task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG theta power in the right dorsolateral prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Surgeon moral distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ipsilateral IPH in patients with RAO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Postoperative S100B levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death or persistent organ dysfunction at 28 days
Endpoint domain: Mortality/survival
Primary endpoint: Fridericia corrected QTc interval change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Grade 3-4 cardiac adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Undetectable Minimal Residual Disease (uMRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DASH work subscale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: end-inspiratory volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: electrical activity of inspiratory muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in FACT-P total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain during LNG-IUS insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of procedure
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient-reported success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compressive strength (CS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rapid antidepressant effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: antisuicidal effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher risk of ALS associated with HDL-C levels
Endpoint domain: Mortality/survival
Primary endpoint: Implementation of FOCS programme
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: post-quiz scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall triage accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip disability and Osteoarthritis Outcome Score quality of life subscale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ease of attending appointments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compliance with home exercise programme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of influenza and other adult vaccinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality rates among PLHIV
Endpoint domain: Mortality/survival
Primary endpoint: PES (Pink Esthetic Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flare onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Component Summary of SF-36
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ao SBP × HR (Aortic Systolic Blood Pressure multiplied by Heart Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: information on the key secondary endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in renal tubular injury biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Improvement in vascular calcification levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: acute and chronic postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life in the early and delayed postoperative periods
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: failure-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: grade 3 acute adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Reports of childhood sexual abuse
Endpoint domain: Adverse events/effects
Primary endpoint: Reports of rape
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of victimization
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of iSupport
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: regional pressure pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time of device positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct depth achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance in M/PM diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDE diagnostic accuracy (sensitivity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDE diagnostic accuracy (specificity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: progression-free survival (PFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: total short-term effective rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance between UBTC and LSFN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone density of the bony partition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to 5 Choosing Wisely guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: financial burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: stress on families
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: lower levels of hazardous drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: child socio-emotional development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of support for chronic illness care implementation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Achieving target correction rate within 1 hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of relowering treatment
Endpoint domain: Adverse events/effects
Primary endpoint: AMS incidence
Endpoint domain: Mortality/survival
Primary endpoint: LLS (Lake Louise Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood oxygen saturation level (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintaining MR3.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum TT level improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cognition test speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition test accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: balance tests improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total postoperative dose of opiates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive performance on TPT shapes subtest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fasting composite appetite scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival in HCC patients
Endpoint domain: Mortality/survival
Primary endpoint: Number of days missed from school
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Effectiveness of HIIT on GAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of complications reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of locoregional failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate bowel preparation (BBPS score ≥ 6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time of hospital discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Return to baseline health
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Severity of dental compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of persistent flares
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in emotional problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in problems with peers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in prosocial scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Auscultation performance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Individual stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feeling of cyclical mastalgia
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Plasma level of high‐sensitivity C‐reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total plasma glutathione
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stroke or systemic arterial embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AF episodes ≥24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean latency until delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Cervical length after 1 week of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: levels of ageism
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: negative age stereotypes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: positive age stereotypes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness in management of ascites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Side effect profile of eplerenone
Endpoint domain: Adverse events/effects
Primary endpoint: knowledge and skills attainment post-training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge and skills retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social Competence (SC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subject satisfaction with treatment outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in GLSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inappropriate weight for gestational age (IWGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative eyelid height stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate during injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain scores (SEM and FPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lip/cheek biting events
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative cognitive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: sedation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of otorrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Normal audiological function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Muscle oxygen utilization (ΔHHb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular strength (MViC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: youth employment
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: receipt of job-related training
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: total income
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Raxibacumab exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure Pain Threshold (PPT) over the median nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure Pain Threshold (PPT) over the radial nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Function and depressive levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RSAbest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RSAtotal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CoD speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum triacylglycerols concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum high-density lipoprotein cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stimulated C peptide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: FEDSS score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAS score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excess risk of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: hypoxemia improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ventilator-free survival
Endpoint domain: Mortality/survival
Primary endpoint: secondary bacterial infection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy for bone metastasis prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in BPI item 6 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time in hyperglycemia >250 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of time in range 70‐250 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: muscle damage biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction of headache intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive accuracy of the patient-derived tumor organoid model for chemotherapy responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ThS (Total Strength)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full-squat strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TVR rates
Endpoint domain: Mortality/survival
Primary endpoint: symptoms of PTSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to sputum culture conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to 50% lesion absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving seroresponse at day 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titers for serogroups C, W, and Y
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Knee joint VAS resting and motion scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention and executive function scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Symptom Inventory (BSI-18) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fractional anisotropy (FA) of left amygdala tracts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNFα release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes